796 related articles for article (PubMed ID: 18385778)
21. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
[TBL] [Abstract][Full Text] [Related]
22. Castleman's disease-associated neuropathy: no evidence of human herpesvirus type 8 infection.
Zumo L; Grewal RP
J Neurol Sci; 2002 Mar; 195(1):47-50. PubMed ID: 11867073
[TBL] [Abstract][Full Text] [Related]
23. Outcomes in Kaposi's sarcoma-associated herpesvirus -associated primary effusion lymphoma and multicentric Castleman's disease in patients with human immunodeficiency virus (HIV) in a safety-net hospital system.
Lopez M; Kainthla R; Lazarte S; Chen W; Nijhawan AE; Knights S
Eur J Haematol; 2024 May; 112(5):723-730. PubMed ID: 38155405
[TBL] [Abstract][Full Text] [Related]
24. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
[TBL] [Abstract][Full Text] [Related]
25. Manifestations of three HHV-8-related diseases in an HIV-negative patient: immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma.
Codish S; Abu-Shakra M; Ariad S; Zirkin HJ; Yermiyahu T; Dupin N; Boshoff C; Sukenik S
Am J Hematol; 2000 Dec; 65(4):310-4. PubMed ID: 11074561
[TBL] [Abstract][Full Text] [Related]
26. Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's disease.
Reid E; Nooka A; Blackmon J; Lechowicz MJ
Curr Drug Deliv; 2012 Jan; 9(1):41-51. PubMed ID: 22023215
[TBL] [Abstract][Full Text] [Related]
27. Castleman's disease: systematic analysis of 416 patients from the literature.
Talat N; Schulte KM
Oncologist; 2011; 16(9):1316-24. PubMed ID: 21765191
[TBL] [Abstract][Full Text] [Related]
28. Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma.
Yaghoobi R; Pazyar N; Tavakoli S
Indian J Dermatol; 2015; 60(3):323. PubMed ID: 26120185
[TBL] [Abstract][Full Text] [Related]
29. Potential heterosexual Kaposi's sarcoma-associated herpesvirus transmission in a couple with HIV-induced immunodepression and with Kaposi's sarcoma and multicentric Castleman's disease.
Tirelli U; Gaidano G; Errante D; Carbone A
AIDS; 1996 Sep; 10(11):1291-2. PubMed ID: 8883593
[No Abstract] [Full Text] [Related]
30. Severe polyneuropathy: initial manifestation of Castleman's disease associated with POEMS syndrome.
Ku A; Lachmann E; Tunkel R; Nagler W
Arch Phys Med Rehabil; 1995 Jul; 76(7):692-4. PubMed ID: 7605193
[TBL] [Abstract][Full Text] [Related]
31. Clinical response to liposomal doxorubicin and rituximab in HHV-8-associated multicentric Castleman's disease in an HIV-positive patient.
Osa M; Maeda T; Misawa K; Imai K; Fujikura Y; Kawana A
J Infect Chemother; 2016 Dec; 22(12):804-807. PubMed ID: 27373909
[TBL] [Abstract][Full Text] [Related]
32. HIV-associated multicentric Castleman's disease.
Stebbing J; Pantanowitz L; Dayyani F; Sullivan RJ; Bower M; Dezube BJ
Am J Hematol; 2008 Jun; 83(6):498-503. PubMed ID: 18260115
[TBL] [Abstract][Full Text] [Related]
33. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
[TBL] [Abstract][Full Text] [Related]
34. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
35. [Incomplete POEMS syndrome with multicentric Castleman's disease].
González de la Aleja P; García-Navarro M; Sánchez-Martínez R; Ramos JM
An Sist Sanit Navar; 2017 Dec; 40(3):475-478. PubMed ID: 28906499
[TBL] [Abstract][Full Text] [Related]
36. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.
van Rhee F; Wong RS; Munshi N; Rossi JF; Ke XY; Fosså A; Simpson D; Capra M; Liu T; Hsieh RK; Goh YT; Zhu J; Cho SG; Ren H; Cavet J; Bandekar R; Rothman M; Puchalski TA; Reddy M; van de Velde H; Vermeulen J; Casper C
Lancet Oncol; 2014 Aug; 15(9):966-74. PubMed ID: 25042199
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous Kaposi's sarcoma and Castleman's disease in a HIV-negative patient. Response to rituximab and doxorubicin.
García-Arpa M; Calle-Primo C; Martín-Dávila F
Med Clin (Barc); 2020 Dec; 155(12):565-566. PubMed ID: 31759694
[No Abstract] [Full Text] [Related]
38. Treatment of multicentric Castleman's Disease accompanying multiple myeloma with bortezomib: a case report.
Yuan ZG; Dun XY; Li YH; Hou J
J Hematol Oncol; 2009 Apr; 2():19. PubMed ID: 19400935
[TBL] [Abstract][Full Text] [Related]
39. Multicentric, Hyaline Vascular Variant of Castleman's Syndrome.
Mukta V; Susmitha C; Kar R; Basu D; Das AK
Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):126-30. PubMed ID: 25332557
[TBL] [Abstract][Full Text] [Related]
40. Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman's Disease: a case report.
Anderson S; Sasson SC; Lee FJ; Cooper W; Larsen S; Garsia R
BMC Infect Dis; 2016 Feb; 16():53. PubMed ID: 26831502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
